penester 5 mg apvalkotās tabletes
zentiva, k.s., czech republic - finasterīds - apvalkotā tablete - 5 mg
androfin 5 mg apvalkotās tabletes
g.l. pharma gmbh, austria - finasterīds - apvalkotās tabletes - 5 mg
finasterid actavis 5 mg apvalkotās tabletes
actavis group hf, iceland - finasterīds - apvalkotās tabletes - 5 mg
finasteride accord 1 mg apvalkotās tabletes
accord healthcare b.v., netherlands - finasterīds - apvalkotā tablete - 1 mg
finster 5 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - finasterīds - apvalkotā tablete - 5 mg
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfoma, mantle-cell - antineoplastiski līdzekļi - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiski līdzekļi - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
lemtrada
sanofi belgium - alemtuzumab - multiplā skleroze - selective immunosuppressants - lemtrada indicēts pieaugušiem pacientiem ar recidivējoši-remitējošu multiplo sklerozi (rrms) ar aktīvu slimību, ko nosaka klīniskas vai attēlveidošanas funkcijas.
endoxan 50 mg apvalkotās tabletes
baxter latvia, sia, latvia - ciklofosfamīds - apvalkotā tablete - 50 mg